$FHLD
Freedom Holdings, Inc.

2023 Q3 Form 10-Q Financial Statement

#000147793223006283 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $921.00 $236.00
YoY Change 290.25% -79.39%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $353.5K $793.00
YoY Change 44480.08% -78.68%
Operating Profit -$353.5K -$793.00
YoY Change 44480.08% -78.68%
Interest Expense $2.932K $101.00
YoY Change 2802.97% -97.45%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$356.5K -$311.7M
YoY Change -99.89% 4061125.24%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 55.31M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $588.00 $294.00 $1.920K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $588.00 $294.00 $1.920K
YoY Change 232.2% -84.69%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $588.00 $294.00 $1.920K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $588.00 $294.00 $1.920K
YoY Change 232.2% -84.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $44.50K $48.69K $45.69K
YoY Change -0.42% 6.57%
Accrued Expenses $241.3K $241.6K $244.3K
YoY Change -0.97% -1.1%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $286.1K $327.0K $315.3K
YoY Change -10.71% 3.72%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $126.4K
YoY Change 37.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $286.1K $327.0K $315.3K
Total Long-Term Liabilities $126.4K
Total Liabilities $412.5K $414.9K $408.7K
YoY Change -0.04% 1.52%
SHAREHOLDERS EQUITY
Retained Earnings -$10.18M -$10.17M -$9.772M
YoY Change 4.09% 4.08%
Common Stock $5.531K $5.531K $931.00
YoY Change 494.09% 494.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$411.9K -$414.6K -$406.8K
YoY Change
Total Liabilities & Shareholders Equity $588.00 $294.00 $1.920K
YoY Change 232.2% -84.69%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$356.5K -$311.7M
YoY Change -99.89% 4061125.24%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
177 usd
CY2022Q3 us-gaap Assets
Assets
177 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9308825 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001386044
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
fhld Issuance Of Stock For Acquisitions
IssuanceOfStockForAcquisitions
0 usd
us-gaap Estimate Of Cancellations
EstimateOfCancellations
0 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54853
dei Entity Registrant Name
EntityRegistrantName
FREEDOM HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2560951
dei Entity Address Address Line1
EntityAddressAddressLine1
10524 Independence Ave.
dei Entity Address City Or Town
EntityAddressCityOrTown
Chatsworth
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91311
dei City Area Code
CityAreaCode
813
dei Local Phone Number
LocalPhoneNumber
699-4098
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55308825 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
294 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
294 usd
CY2023Q2 us-gaap Assets
Assets
294 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
48688 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
44687 usd
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
321 usd
CY2022Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
574 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
241649 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
243654 usd
CY2023Q2 fhld Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
36355 usd
CY2022Q3 fhld Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
31530 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
327013 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
320445 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
87897 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
92203 usd
CY2023Q2 us-gaap Liabilities
Liabilities
414910 usd
CY2022Q3 us-gaap Liabilities
Liabilities
412648 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55308825 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
5531 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
931 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9765828 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9364428 usd
CY2023Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
15000 usd
CY2022Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
0 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10170975 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9777830 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-414616 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-412471 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
294 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
177 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
351000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
351000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
1599 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
557 usd
us-gaap Professional Fees
ProfessionalFees
29647 usd
us-gaap Professional Fees
ProfessionalFees
69427 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
921 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
236 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3556 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4080 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
353520 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
793 usd
us-gaap Operating Expenses
OperatingExpenses
384203 usd
us-gaap Operating Expenses
OperatingExpenses
73507 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-353520 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-793 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-384203 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-73507 usd
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
-311672729 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
27000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
27000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
2932 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
-101 usd
us-gaap Interest Expense
InterestExpense
8942 usd
us-gaap Interest Expense
InterestExpense
9499 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-356452 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
311699037 usd
us-gaap Net Income Loss
NetIncomeLoss
-393145 usd
us-gaap Net Income Loss
NetIncomeLoss
-56006 usd
CY2023Q2 fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.01
CY2022Q2 fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
1.02
fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.01
fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.00
CY2023Q2 fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
50056078 shares
CY2022Q2 fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
304106332 shares
fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
31096371 shares
fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
211286080 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-349792 usd
CY2022 fhld Cancellation Of Common Stock Amount
CancellationOfCommonStockAmount
-980 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-61698 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-412471 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
35000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
351000 usd
fhld Sold Stock For Cash Amount
SoldStockForCashAmount
5000 usd
us-gaap Net Income Loss
NetIncomeLoss
-393145 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-414616 usd
us-gaap Profit Loss
ProfitLoss
-393145 usd
us-gaap Profit Loss
ProfitLoss
-56006 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
351000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
1996 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
35945 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-253 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-171 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40402 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20232 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-4306 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-3530 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
4825 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
24530 usd
fhld Issuance Of Stock For Acquisitions
IssuanceOfStockForAcquisitions
35000 usd
us-gaap Estimate Of Cancellations
EstimateOfCancellations
-980 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
5000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40519 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20020 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
117 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-212 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
294 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1920 usd
us-gaap Interest Paid Net
InterestPaidNet
6153 usd
us-gaap Interest Paid Net
InterestPaidNet
9499 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash. </p>
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
294 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177 usd
us-gaap Net Income Loss
NetIncomeLoss
-393145 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000 usd
CY2023Q1 fhld Amount Paid Purchase Price
AmountPaidPurchasePrice
30000 usd
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55308825 shares
us-gaap Share Based Compensation
ShareBasedCompensation
351000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10170975 usd
CY2017Q3 us-gaap Unsecured Debt
UnsecuredDebt
50000 usd
CY2017Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
750 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
87897 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
92203 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
321 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
574 usd
CY2023Q2 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
88218 usd
CY2022Q3 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
92777 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
241649 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
243654 usd
CY2021Q4 fhld Preferred Stock Description
PreferredStockDescription
On December 30, 2021, the Company converted all of the 710,676 shares of issued and outstanding preferred stock consisting of Series A, B, C and D preferred stock, into 15,920,945 shares of common stock.
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
40000000 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.00125
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9308825 shares

Files In Submission

Name View Source Status
0001477932-23-006283-index-headers.html Edgar Link pending
0001477932-23-006283-index.html Edgar Link pending
0001477932-23-006283.txt Edgar Link pending
0001477932-23-006283-xbrl.zip Edgar Link pending
fhld-20230630.xsd Edgar Link pending
fhld_10q.htm Edgar Link pending
fhld_ex311.htm Edgar Link pending
fhld_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
fhld-20230630_def.xml Edgar Link unprocessable
fhld-20230630_lab.xml Edgar Link unprocessable
fhld-20230630_cal.xml Edgar Link unprocessable
fhld-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
fhld_10q_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending